Literature DB >> 20607218

Effects of exogenous glutathione on arsenic burden and NO metabolism in brain of mice exposed to arsenite through drinking water.

Yan Wang1, Fenghong Zhao, Yaping Jin, Yuan Zhong, Xiaoyun Yu, Gexin Li, Xiuqiang Lv, Guifan Sun.   

Abstract

Chronic exposure to inorganic arsenic (iAs) is associated with neurotoxicity. Studies to date have disclosed that methylation of ingested iAs is the main metabolic pathway, and it is a process relying on reduced glutathione (GSH). The aim of this study was to explore the effects of exogenous GSH on arsenic burden and metabolism of nitric oxide (NO) in the brain of mice exposed to arsenite via drinking water. Mice were exposed to sodium arsenite through drinking water contaminated with 50 mg/L arsenic for 4 weeks and treated intraperitoneally with saline solution, 200 mg/kg body weight (b.w), 400 mg/kg b.w, or 800 mg/kg b.w GSH, respectively, at the 4th week. Levels of iAs, monomethylarsenic acid, and dimethylarsenic acid (DMAs) in the liver, blood, and brain were determined by method of hydride generation coupled with atomic absorption spectrophotometry. Activities of nitric oxide synthase (NOS) and contents of NO in the brain were determined by colorimetric method. Compared with mice exposed to arsenite alone, administration of GSH increased dose-dependently the primary and secondary methylation ratio in the liver, which caused the decrease in percent iAs and increase in percent DMAs in the liver, as a consequence, resulted in significant decrease in iAs levels in the blood and total arsenic levels in both blood and brain. NOS activities and NO levels in the brain of mice in iAs group were significantly lower than those in control; however, administration of GSH could increase significantly activities of NOS and contents of NO. Findings from this study suggested that exogenous GSH could promote both primary and secondary arsenic methylation capacity in the liver, which might facilitate excretion of arsenicals, and consequently reduce arsenic burden in both blood and brain and furthermore ameliorate the effects of arsenicals on NO metabolism in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607218     DOI: 10.1007/s00204-010-0573-1

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  9 in total

1.  Recognition of early and late stages of bladder cancer using metabolites and machine learning.

Authors:  Valentina L Kouznetsova; Elliot Kim; Eden L Romm; Alan Zhu; Igor F Tsigelny
Journal:  Metabolomics       Date:  2019-06-20       Impact factor: 4.290

Review 2.  Uptake, Metabolic Effects and Toxicity of Arsenate and Arsenite in Astrocytes.

Authors:  Ralf Dringen; Sabrina Spiller; Sarah Neumann; Yvonne Koehler
Journal:  Neurochem Res       Date:  2015-04-11       Impact factor: 3.996

3.  Arsenate stimulates glutathione export from viable cultured rat cerebellar granule neurons.

Authors:  Michaela C Hohnholt; Eva-Maria Blumrich; Yvonne Koehler; Ralf Dringen
Journal:  Neurochem Res       Date:  2014-12-12       Impact factor: 3.996

4.  Effects of Glycyrrhetinic Acid on GSH Synthesis Induced by Realgar in the Mouse Hippocampus: Involvement of System [Formula: see text], System [Formula: see text], MRP-1, and Nrf2.

Authors:  Yan-Lei Wang; Mo Chen; Tao-Guang Huo; Ying-Hua Zhang; Ying Fang; Cong Feng; Shou-Yun Wang; Hong Jiang
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

Review 5.  The gut microbiome and arsenic-induced disease-iAs metabolism in mice.

Authors:  Yifei Yang; Liang Chi; Yunjia Lai; Yun-Chung Hsiao; Hongyu Ru; Kun Lu
Journal:  Curr Environ Health Rep       Date:  2021-04-14

6.  Key messages of recent publications in the field of toxicology.

Authors:  C Cadenas; R Marchan; P Godoy; R Reif; I von Recklinghausen; N Schöbel
Journal:  EXCLI J       Date:  2012-11-09       Impact factor: 4.068

7.  The Release of Nitric Oxide Is Involved in the β-Arrestin1-Induced Antihypertensive Effect in the Rostral Ventrolateral Medulla.

Authors:  Jia-Cen Sun; Xing Tan; Lian-Jie Ge; Ming-Juan Xu; Wei-Zhong Wang
Journal:  Front Physiol       Date:  2021-06-18       Impact factor: 4.566

8.  Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease.

Authors:  Xiang-Yun Li; Guang-Hai Mei; Qiang Dong; Yu Zhang; Zhuang-Li Guo; Jing-Jing Su; Yu-Ping Tang; Xue-Hong Jin; Hou-Guang Zhou; Yan-Yan Huang
Journal:  Parkinsons Dis       Date:  2015-11-18

Review 9.  The History, Status, Gaps, and Future Directions of Neurotoxicology in China.

Authors:  Tongjian Cai; Wenjing Luo; Diyun Ruan; Yi-Jun Wu; Donald A Fox; Jingyuan Chen
Journal:  Environ Health Perspect       Date:  2016-01-29       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.